SENSEX NIFTY

Ranbaxy Laboratories

BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, :
859.90
0
VOLUME 308,222
Ranbaxy Laboratories is not traded in the last 30 days
Stocks attracting Fund Managers
Check out MF Action in another Stock:

    Ranbaxy Laboratories traded by Mutual Fund Schemes

     
    Not held by Mutual Funds in the last 6 quarters
SCHEME NAME Jun '16 Mar '16 Dec '15 Sep '15 Jun '15 Mar '15
 
AUM
(Rs. cr.)
No. of
share
%
No. of share No. of share No. of share No. of share No. of share
Birla SL Enhanced Arbit.-Direct (G)-- -- - - - 17,925
Birla SL Enhanced Arbitrage-RP (G)-- -- - - - 6,996
Birla SL Focused Equity-Sr 1-DP (G)-- -- - - - 91
Birla SL Focused Equity-Sr 1-RP (G)-- -- - - - 18,917
Birla SL Focused Equity-Sr 2-DP (G)-- -- - - - 190
Birla SL Focused Equity-Sr 2-RP (G)-- -- - - - 14,295
Birla SL Focused Equity-Sr 3-DP (G)-- -- - - - 170
Birla SL Focused Equity-Sr 3-RP (G)-- -- - - - 31,487
Birla SL Focused Equity-Sr 4-DP (G)-- -- - - - 141
Birla SL Focused Equity-Sr 4-RP (G)-- -- - - - 20,429
Birla SL Focused Equity-Sr 5-DP (G)-- -- - - - 15
Birla SL Focused Equity-Sr 5-RP (G)-- -- - - - 1,913
Birla SL Frontline Eqty-Direct (G)-- -- - - - 18,874
Birla SL Frontline Equity (G)-- -- - - - 213,499
Birla SL India GenNext (G)-- -- - - - 45,909
Birla SL India GenNext-Direct (G)-- -- - - - 3,381
Birla SL Long Term Adv. -Direct (G)-- -- - - - 1,379
Birla SL Long Term Advan. (G)-- -- - - - 42,966
Birla SL MNC Fund -Direct (G)-- -- - - - 2,028
Birla SL Top 100 - Direct (G)-- -- - - - 7,764
Birla Sun Life MNC Fund (G)-- -- - - - 55,103
Birla Sun Life Top 100 (G)-- -- - - - 145,519
Edelweiss Absolute Return Fund (G)-- -- - - - 145,730
Edelweiss Absolute Return-Direct(G)-- -- - - - 6,642
Edelweiss E.D.G.E. Top 100 -A (G)-- -- - - - 13,656
Edelweiss E.D.G.E. Top 100 -B (G)-- -- - - - 236
Edelweiss E.D.G.E. Top 100 -C (G)-- -- - - - 155
Edelweiss EDGE Top 100 -Direct (G)-- -- - - - 311
Edelweiss ELSS Fund (G)-- -- - - - 8,864
Edelweiss ELSS Fund - Direct (G)-- -- - - - 139
Escorts Balanced Fund (G)-- -- - - - 1,099
Escorts Balanced Fund - Direct (G)-- -- - - - 173
Escorts Growth Plan (G)-- -- - - - 2,230
Escorts Growth Plan - Direct (G)-- -- - - - 113
Escorts Leading Sectors (G)-- -- - - - 1,148
Escorts Leading Sectors -Direct (G)-- -- - - - 29
Escorts Opportunities - Direct (G)-- -- - - - 26
Escorts Opportunities Fund (G)-- -- - - - 11,508
ICICI Pru Eqty-Arbitrage-Direct (G)-- -- - - - 42,777
ICICI Pru Eqty-Arbitrage-DP (Bonus)-- -- - - - 42,777
ICICI Pru Equity Income Fund-DP (G)-- -- - - - 4,420
ICICI Pru Equity Income Fund-RP (G)-- -- - - - 228,903
ICICI Pru Equity-Arbitrage- IP (G)-- -- - - - -
ICICI Pru Equity-Arbitrage- RP (G)-- -- - - - 83,276
IDFC Arbitrage - Inst (G)-- -- - - - 1,702
IDFC Arbitrage Fund - Direct (G)-- -- - - - 61,184
IDFC Arbitrage Fund - Regular (G)-- -- - - - 103,674
IDFC Arbitrage Plus - Regular (G)-- -- - - - 29,656
IDFC Arbitrage Plus-B (G)-- -- - - - 8
L&T India Prudence Fund (G)-- -- - - - 27,206
L&T India Prudence Fund -Direct (G)-- -- - - - 1,075
L&T India Special Situations -Direct (G)-- -- - - - 4,725
L&T India Special Situations(G)-- -- - - - 270,024
LIC NOMURA MIP (G)-- -- - - - 998
LIC NOMURA MIP - Direct (G)-- -- - - - 26
Reliance Arbitrage Adv.- Direct (G)-- -- - - - 72,365
Reliance Arbitrage Advantage (G)-- -- - - - 164,007
Reliance Pharma Fund (G)-- -- - - - 648,077
Reliance Pharma Fund - Direct (G)-- -- - - - 41,753
Reliance Top 200 - Direct (G)-- -- - - - 3,665
Reliance Top 200 Fund-RP (G)-- -- - - - 134,102
SBI - ETF BSE 100-- -- - - - 535
SBI Balanced Fund - Direct (G)-- -- - - - 23,875
SBI Blue Chip Fund (G)-- -- - - - 460,495
SBI Blue Chip Fund - Direct (G)-- -- - - - 38,996
SBI Capital Protection Fund- Sr-II-- -- - - - 19,829
SBI Contra Fund (G)-- -- - - - 597,272
SBI Contra Fund - Direct (G)-- -- - - - 6,474
SBI Equity Oppor. Sr-2 - Direct (G)-- -- - - - 3,479
SBI Equity Oppor. Sr-2 - Regular (G)-- -- - - - 100,658
SBI Magnum Balanced Fund (G)-- -- - - - 345,128
SBI Magnum Equity Fund (G)-- -- - - - 394,044
SBI Magnum Equity Fund - Direct (G)-- -- - - - 29,899
SBI Magnum Multicap Fund (G)-- -- - - - 135,752
SBI Magnum Multicap Fund - Direct (G)-- -- - - - 1,574
SBI Pharma Fund (G)-- -- - - - 376,660
SBI Pharma Fund - Direct (G)-- -- - - - 53,460
Sundaram Eqty Multiplier-Direct (G)-- -- - - - 97
Sundaram Equity Multiplier (G)-- -- - - - 30,347
Sundaram Equity Plus (G)-- -- - - - 26,203
Sundaram Equity Plus -Direct (G)-- -- - - - 1,899
UTI Balanced Fund (G)-- -- - - - 262,434
UTI Balanced Fund - Direct (G)-- -- - - - 1,514
UTI CCP Advantage Fund (G)-- -- - - - 24,397
UTI CCP Advantage Fund - Direct (G)-- -- - - - 303
UTI CPOS-Sr IV- II (1104D)- Dir (G)-- -- - - - 268
UTI CPOS-Sr IV- II (1104D)- Reg (G)-- -- - - - 9,665
UTI CPOS-Sr IV- III (1105D)- Dir (G)-- -- - - - 540
UTI CPOS-Sr IV- III (1105D)- Reg (G)-- -- - - - 8,739
UTI CRTS 81 - Direct (G)-- -- - - - 1,047
UTI CRTS 81(G)-- -- - - - 42,913
UTI Mastershare (G)-- -- - - - 33,962
UTI Mastershare - Direct (G)-- -- - - - 507
UTI Mid Cap (G)-- -- - - - 264,975
UTI Mid Cap - Direct (G)-- -- - - - 10,109
UTI MNC Fund (G)-- -- - - - 47,309
UTI MNC Fund - Direct (G)-- -- - - - 2,136
UTI Monthly Income Scheme (G)-- -- - - - 16,470
UTI Monthly Income Scheme-Direct(G)-- -- - - - 216
UTI Pharma & Health (G)-- -- - - - 133,246
UTI Pharma & Health - Direct (G)-- -- - - - 5,474
Total 0 0 0 0 0 6,320,350
Note :
* For schemes that have not disclosed the number of shares, the same has been calculated on the basis of the closing price of the stock on the BSE/NSE as on the portfolio date. The increase/decrease in the share quantity besides the fund buying or selling the shares from the market, could also be due to any bonus, split, rights, or restructuring in the company.
** The numbers in green / red indicate increase /decrease, respectively in the no. of shares over the shares mentioned in the previous month.
PLEASE NOTE : This report is based on the quarter-end portfolios disclosed by AMCs (mutual funds). Starting October 2010, select AMCs have stopped declaring monthly AUM (Assets under Management) and value of the stock in their Portfolio, hence the number of shares for the schemes from these AMCs could not be incorporated in the above report.
For Jun '16, it displays data for 39 out of the total 44 AMCs.
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.